Evidence map›Paper›PMID 38062399›Full record

ArticleBMC psychiatry2023

One case report of epilepsy and rapidly progressive cognitive impairment after levofloxacin treatment.

Zhan Su, Guimei Zhang, Yanxin Shen, Xiangting Li, Zixun Wang, Haining Zhang

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhan SuDepartment of Neurology and Neuroscience Centre, the First Hospital of Jilin University, Changchun, China.
Guimei ZhangDepartment of Neurology and Neuroscience Centre, the First Hospital of Jilin University, Changchun, China.
Yanxin ShenDepartment of Neurology and Neuroscience Centre, the First Hospital of Jilin University, Changchun, China.
Xiangting LiDepartment of Neurology and Neuroscience Centre, the First Hospital of Jilin University, Changchun, China.
Zixun WangDepartment of Neurology and Neuroscience Centre, the First Hospital of Jilin University, Changchun, China.
Haining ZhangDepartment of Neurology and Neuroscience Centre, the First Hospital of Jilin University, Changchun, China. zhanghaining@jlu.edu.cn.
First Hospital of Jilin University · CNJilin University · CN

Funding

the Special Project for Medical and Sanitary Talent of Jilin Province JLSWS-RCZX2021-077
6 · The paper itself

Abstract

objectiveTo report a case of seizure and rapidly progressive cognitive impairment 20 min after intravenous administration of levofloxacin. A 56-year-old woman was admitted to hospital with episodic unconsciousness and unresponsiveness. About 4 days ago, she experienced a loss of consciousness, fell to the floor, and yelled for 2 min, 20 min before the first intravenous dose of levofloxacin. The patient developed symptoms of cognitive impairment after the seizure. Levofloxacin is a synthetic third generation fluoroquinolone used to treat various infectious diseases. Upon admission, the patient was conscious and unresponsive. After 11 days of symptomatic and supportive treatment, the patient was discharged from the hospital with cognition restored to baseline level and no recurrence of seizures 10 months after discharge. DISCUSSION: Epilepsy is a rare adverse reaction to levofloxacin treatment. The patient in this case had infection-related signs before the onset of the disease, and the disease progressed rapidly with fluctuating changes. After ruling out degenerative, infectious, toxic, and autoimmune causes, the patient's symptoms may be attributed to levofloxacin, and this is the first case of seizure and rapidly progressive cognitive impairment after levofloxacin injection reported in the literature. Clinicians should be aware that unexplained, rapidly progressing cognitive impairment with infection-related signs before onset may be a rare side effect of antibiotics.

Indexed as

Cognitive DysfunctionEpilepsyFemaleHumansLevofloxacinMiddle AgedSeizuresLevofloxacinLevofloxacinRapid Progressive cognitive impairmentSeizures

Identifiers

PMID38062399
PMCPMC10704816
OpenAlexW4389432421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.